IDEAYA Biosciences, Inc.
IDYA
$19.13
$0.552.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.00M | -- | -- | -- | 3.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.00M | -- | -- | -- | 3.92M |
| Cost of Revenue | 140.18M | 57.15M | 54.53M | 42.81M | 38.77M |
| Gross Profit | -133.18M | -57.15M | -54.53M | -42.81M | -34.85M |
| SG&A Expenses | 10.96M | 9.74M | 10.39M | 8.21M | 7.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 151.14M | 66.89M | 64.93M | 51.02M | 45.84M |
| Operating Income | -144.14M | -66.89M | -64.93M | -51.02M | -41.92M |
| Income Before Tax | -130.31M | -51.82M | -52.77M | -39.57M | -33.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -130.31M | -51.82M | -52.77M | -39.57M | -33.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -130.31M | -51.82M | -52.77M | -39.57M | -33.96M |
| EBIT | -144.14M | -66.89M | -64.93M | -51.02M | -41.92M |
| EBITDA | -143.57M | -66.32M | -64.31M | -50.40M | -41.29M |
| EPS Basic | -1.49 | -0.60 | -0.68 | -0.53 | -0.52 |
| Normalized Basic EPS | -1.10 | -0.38 | -0.42 | -0.33 | -0.44 |
| EPS Diluted | -1.49 | -0.60 | -0.68 | -0.53 | -0.52 |
| Normalized Diluted EPS | -1.10 | -0.38 | -0.42 | -0.33 | -0.44 |
| Average Basic Shares Outstanding | 87.34M | 86.19M | 77.96M | 75.11M | 65.25M |
| Average Diluted Shares Outstanding | 87.34M | 86.19M | 77.96M | 75.11M | 65.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
